[go: up one dir, main page]

EP4065128A4 - Mixture of hmos for improving the microbiota of pregnant women - Google Patents

Mixture of hmos for improving the microbiota of pregnant women Download PDF

Info

Publication number
EP4065128A4
EP4065128A4 EP20894211.0A EP20894211A EP4065128A4 EP 4065128 A4 EP4065128 A4 EP 4065128A4 EP 20894211 A EP20894211 A EP 20894211A EP 4065128 A4 EP4065128 A4 EP 4065128A4
Authority
EP
European Patent Office
Prior art keywords
hmos
microbiota
improving
mixture
pregnant women
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20894211.0A
Other languages
German (de)
French (fr)
Other versions
EP4065128A1 (en
Inventor
Bruce Mcconnell
Louise Kristine VIGSNÆS
Dorthe SEITZBERG
Ingvild Dybdrodt AMUNDSEN
Buket SOYYILMAZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glycom AS
Original Assignee
Glycom AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycom AS filed Critical Glycom AS
Publication of EP4065128A1 publication Critical patent/EP4065128A1/en
Publication of EP4065128A4 publication Critical patent/EP4065128A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/28—Oligosaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pediatric Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
EP20894211.0A 2019-11-29 2020-11-30 Mixture of hmos for improving the microbiota of pregnant women Pending EP4065128A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201901402 2019-11-29
PCT/IB2020/061258 WO2021105964A1 (en) 2019-11-29 2020-11-30 Mixture of hmos for improving the microbiota of pregnant women

Publications (2)

Publication Number Publication Date
EP4065128A1 EP4065128A1 (en) 2022-10-05
EP4065128A4 true EP4065128A4 (en) 2023-12-20

Family

ID=76130109

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20894211.0A Pending EP4065128A4 (en) 2019-11-29 2020-11-30 Mixture of hmos for improving the microbiota of pregnant women

Country Status (7)

Country Link
US (1) US20230012011A1 (en)
EP (1) EP4065128A4 (en)
JP (1) JP2023503401A (en)
KR (1) KR20220107011A (en)
CN (1) CN114761024A (en)
BR (1) BR112022010061A2 (en)
WO (1) WO2021105964A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115868632A (en) * 2022-11-29 2023-03-31 黑龙江飞鹤乳业有限公司 Nutritional composition containing breast milk oligosaccharide and probiotics, food and application
CN115843880A (en) * 2022-11-29 2023-03-28 黑龙江飞鹤乳业有限公司 Nutritional composition containing breast milk oligosaccharide and osteopontin, food and application
CN115918916A (en) * 2022-11-29 2023-04-07 黑龙江飞鹤乳业有限公司 Nutritional composition containing breast milk oligosaccharide and lactoferrin, food and application
WO2024184259A1 (en) * 2023-03-03 2024-09-12 Chr. Hansen A/S Composition comprising bifidobacterium animalis subsp. lactis strain and 2'-fucosyllactose
KR20240150943A (en) 2023-04-10 2024-10-17 (주)인트젠 Lactic-acid bacteria probiotics composition for infants
WO2024223906A1 (en) * 2023-04-28 2024-10-31 Société des Produits Nestlé S.A. Composition for use in a subject
CN119326133A (en) * 2024-12-20 2025-01-21 飞鹤(阿鲁科尔沁旗)乳品有限公司 Use of nutritional composition for assisting in improving memory ability

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007105945A2 (en) * 2006-03-10 2007-09-20 N.V. Nutricia Use of non-digestable sacharides for giving an infant the best start after birth

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ612455A (en) * 2010-12-31 2015-02-27 Abbott Lab Human milk oligosaccharides to promote growth of beneficial bacteria
EP3193886A1 (en) * 2014-09-15 2017-07-26 N.V. Nutricia Reducing anxiety in progeny
US11957148B2 (en) * 2015-12-15 2024-04-16 Societe Des Produits Nestle S.A. Mixture of human milk oligosaccharides(HMOs)
MX385649B (en) * 2017-05-24 2025-03-18 Nestle Sa A NUTRITIONAL COMPOSITION FOR USE TO IMPROVE ATTENTION AND/OR REDUCE IMPULSIVITY.
WO2019111115A2 (en) * 2017-12-05 2019-06-13 Glycom A/S Human milk oligosaccharides for treating migraine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007105945A2 (en) * 2006-03-10 2007-09-20 N.V. Nutricia Use of non-digestable sacharides for giving an infant the best start after birth

Also Published As

Publication number Publication date
US20230012011A1 (en) 2023-01-12
CN114761024A (en) 2022-07-15
JP2023503401A (en) 2023-01-30
EP4065128A1 (en) 2022-10-05
BR112022010061A2 (en) 2022-09-06
KR20220107011A (en) 2022-08-01
WO2021105964A1 (en) 2021-06-03

Similar Documents

Publication Publication Date Title
EP4065128A4 (en) Mixture of hmos for improving the microbiota of pregnant women
EP3934652A4 (en) Compounds, compositions, and methods for the treatment of disease
AU2019382117A1 (en) Process for the preparation of (S)-nicotin from myosmine
EP3675859A4 (en) Compounds, compositions, and methods for the treatment of disease
EP4065127A4 (en) Mixture of hmos
EP3906043A4 (en) Methods and compositions for the treatment of fabry disease
EP4085916A4 (en) Prophylactic or therapeutic composition for graft-versus-host disease
AU2018279184A1 (en) Anti-TrkB antibodies
IL289904A (en) Process for the preparation of biphenylamines
EP3755711A4 (en) Immunotherapeutic composition for the treatment of cancer
IL291351A (en) Compositions for the treatment of solid tumors
EP3801558A4 (en) Mixture of hmos for treating autoimmune diseases
EP3927375A4 (en) Compositions for disease treatment
EP3820477A4 (en) Compounds, compositions, and methods for the treatment of disease
EP3965876A4 (en) Techniques for stimulation artefact elimination
EP3974541A4 (en) Composition for cancer diagnosis
EP3991794A4 (en) External preparation for skin
EP4028058A4 (en) Compositions and methods for making and using multispecific antibodies
EP3962514A4 (en) Methods and compositions involving tert activating therapies
HK40081044A (en) Mixture of hmos
HK40066286A (en) Compounds, compositions, and methods for the treatment of disease
HK40111370A (en) Process for the preparation of (s)-nicotin from myosmine
HK40111370B (en) Process for the preparation of (s)-nicotin from myosmine
EP4082626A4 (en) Composition for external preparation for skin
HK40066588A (en) Optimized vaccine compositions and methods for making the same

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220519

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20231122

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 35/747 20150101ALI20231116BHEP

Ipc: A61K 35/745 20150101ALI20231116BHEP

Ipc: A23L 29/00 20160101ALI20231116BHEP

Ipc: A61P 37/00 20060101ALI20231116BHEP

Ipc: A61P 25/00 20060101ALI20231116BHEP

Ipc: A61P 1/06 20060101ALI20231116BHEP

Ipc: A61K 31/125 20060101ALI20231116BHEP

Ipc: A61K 31/702 20060101AFI20231116BHEP